Beam Therapeutics Income Statement (2019-2025) | BEAM

1Y3Y5Y7Y10YAll
Download Data
Income Statement Mar2019 Jun2019 Sep2019 Dec2019 Mar2020 Jun2020 Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025
Revenue & cost
Revenue 0.01M0.01M0.01M0.01M0.01M0.01M0.01M0.01M0.76M51.07M8.43M16.65M15.80M20.04M24.21M20.12M17.19M316.19M7.41M11.77M14.27M30.07M7.47M8.47M9.70M
Operating items
Research & Development 9.18M12.54M20.22M21.55M19.35M29.82M32.45M190.11M45.58M54.62M96.78M65.41M74.56M85.29M86.34M99.65M97.61M100.05M140.08M84.82M87.04M94.26M101.44M98.82M101.76M109.77M
Selling, General & Administrative 3.93M5.49M6.16M6.81M6.94M7.50M8.35M10.27M13.40M15.77M17.77M19.25M24.06M21.82M22.68M23.49M24.66M25.41M43.26M26.72M29.63M26.52M28.66M27.94M26.86M26.74M
Other Operating Expenses -0.50M-0.98M-1.48M-2.10M-7.93M2.87M-54.66M-1.19M
Operating Expenses 13.11M18.03M26.38M28.36M26.29M37.33M40.80M200.38M58.98M70.40M114.55M84.66M98.62M107.10M109.02M123.14M122.26M125.46M183.33M111.54M116.67M120.77M130.10M126.76M128.62M136.51M
Operating Income -13.11M-18.02M-26.37M-28.36M-26.29M-37.32M-40.80M-200.37M-58.97M-69.63M-63.48M-76.22M-81.97M-91.30M-88.98M-98.93M-102.15M-108.27M132.86M-104.13M-104.89M-106.50M-100.04M-119.29M-120.15M-126.81M
EBIT -13.11M-18.02M-26.37M-28.36M-26.29M-37.32M-40.80M-200.37M-58.97M-69.63M-63.48M-76.22M-81.97M-91.30M-88.98M-98.93M-102.15M-108.27M132.86M-104.13M-104.89M-106.50M-100.04M-119.29M-120.15M-126.81M
Non-operating items
Interest & Investment Income 0.50M0.62M0.32M0.60M0.25M0.17M0.04M-0.02M-0.05M0.01M0.05M0.64M2.06M4.98M7.61M9.96M11.95M12.70M12.06M11.85M14.19M12.13M10.93M9.86M12.33M10.90M
Other Non Operating Income -1.00M-1.60M-1.80M-2.70M-8.70M2.70M-54.70M-1.90M-42.30M35.80M7.40M13.60M12.20M-4.90M3.00M5.60M-0.90M4.70M-1.90M-2.90M5.50M-0.20M-0.13M2.26M1.15M-2.76M
Non Operating Income -2.10M2.87M-54.66M-1.19M-17.28M41.52M-1.22M7.01M10.02M9.64M51.64M2.47M19.37M12.18M11.30M5.46M13.88M9.84M9.68M10.02M17.86M14.08M
Net income details
EBT -12.61M-17.41M-26.05M-27.76M-26.04M-37.15M-40.76M-200.39M-59.03M-28.12M-64.71M-75.58M-79.91M-81.67M-37.35M-88.97M-96.46M-96.09M144.16M-92.28M-98.67M-96.67M-90.35M-109.42M-109.27M-112.73M
Tax Provisions 2.41M1.00M1.40M0.04M0.06M
Profit After Tax -13.61M-19.00M-27.85M-30.46M-34.22M-34.45M-95.46M-201.56M-76.25M-28.12M-64.71M-69.21M-71.95M-109.58M-38.35M-96.46M-82.78M-96.09M142.80M-98.67M-91.05M-96.67M-90.35M-109.27M-102.29M-112.73M
Equity Income 1.04M25.81M-4.89M-4.27M-7.68M-4.12M-25.50M-12.80M6.15M-11.22M-0.72M-3.35M-7.59M-2.06M-1.09M-2.08M4.42M4.94M
Income from Continuing Operations -12.61M-17.41M-26.05M-27.76M-26.04M-37.15M-40.76M-200.39M-59.03M-28.12M-64.71M-75.58M-79.91M-84.08M-38.35M-88.97M-96.46M-96.09M142.76M-92.28M-98.71M-96.67M-90.42M-109.42M-109.27M-112.73M
Consolidated Net Income -12.61M-17.41M-26.05M-27.76M-26.04M-37.15M-40.76M-200.39M-59.03M-28.12M-64.71M-75.58M-79.91M-84.08M-38.35M-88.97M-96.46M-96.09M142.76M-92.28M-98.71M-96.67M-90.42M-109.42M-109.27M-112.73M
Income towards Parent Company -12.61M-17.41M-26.05M-27.76M-26.04M-37.15M-40.76M-200.39M-59.03M-28.12M-64.71M-75.58M-79.91M-84.08M-38.35M-88.97M-96.46M-96.09M142.76M-92.28M-98.71M-96.67M-90.42M-109.42M-109.27M-112.73M
Preferred Dividend Payments 2.96M3.26M3.26M1.28M
Net Income towards Common Stockholders -16.57M-22.27M-31.11M-31.73M-34.22M-34.45M-95.46M-201.56M-76.25M-28.12M-64.71M-69.21M-71.95M-109.58M-38.35M-96.46M-82.78M-96.09M142.80M-98.67M-91.05M-96.67M-90.35M-109.27M-102.29M-112.73M
Additional items
EPS (Basic) -2.88-3.31-4.47-1.03-0.69-0.69-1.88-3.35-1.23-0.42-0.91-1.01-1.02-1.56-0.54-1.33-1.08-1.221.91-1.21-1.11-1.17-1.09-1.24-1.00-1.10
EPS (Weighted Average and Diluted) -4.80-0.96-0.69-1.88-3.35-1.23-0.42-0.91-1.01-1.02-1.56-0.54-1.33-1.08-1.221.91-1.21-1.11-1.17-1.09-1.24-1.00-1.10
Shares Outstanding (Weighted Average) 45.32M45.32M51.34M51.49M51.73M51.73M57.97M62.42M66.35M66.35M68.14M68.73M70.27M70.35M70.47M72.40M76.22M79.20M81.50M81.66M82.31M82.42M82.81M83.69M100.56M101.16M
Shares Outstanding (Diluted Average) 6.48M49.43M50.09M46.73M60.21M62.21M66.38M64.23M68.70M70.21M70.34M70.02M72.27M76.34M79.02M77.15M81.70M82.31M82.41M82.31M87.98M102.00M102.57M
EBITDA -13.61M-19.04M-27.88M-30.82M-33.70M-34.58M-95.51M-201.57M-76.20M-28.13M-64.78M-71.87M-73.43M-110.06M-36.10M-94.80M-84.03M-96.10M145.43M-100.19M-91.24M-93.80M-91.43M-109.79M-102.44M-111.95M
Shares Outstanding 5.98M6.43M6.90M7.33M49.08M49.65M50.44M57.25M61.74M64.45M67.73M68.39M69.75M70.31M70.46M71.28M74.44M77.95M79.38M81.63M82.28M82.39M82.56M83.63M100.56M100.76M101.36M
Tax Rate 0.97